Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Mepitel film acute radiation dermatitis breast cancer patient reported outcomes, meta-analysis skin toxicity systematic review

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
16 Aug 2023
Historique:
received: 17 05 2023
accepted: 01 08 2023
medline: 17 8 2023
pubmed: 16 8 2023
entrez: 16 8 2023
Statut: epublish

Résumé

This systematic review and meta-analysis aimed to evaluate the efficacy of Mepitel film in preventing or treating acute radiation dermatitis (RD) in patients with breast cancer in randomized controlled trials (RCTs). Embase, APA PsychInfo, Journals@Ovid Full Text, Ovid MEDLINE, PubMed, and Cochrane Trials were searched until December 12, 2022, to identify RCTs on the use of Mepitel film for preventing or treating acute RD from breast cancer radiotherapy. Per-protocol analysis was used to compare outcomes, calculate pooled effect sizes, odds ratio (OR), and 95% confidence intervals (CI), and to create forest plots using random effects analysis in RevMan 5.4. Three RCTs were included in this review. Mepitel film significantly reduced the incidence of grade 3 RD (OR 0.15 95% CI 0.06, 0.37, p<0.0001) and grade 2 or 3 RD (OR 0.16 95% CI 0.04, 0.65, p=0.01) as scored on either the CTCAE or the RTOG scale. Additionally, Mepitel film significantly reduced RISRAS mean scores assessed by patients and combined researcher and patient (standardized mean difference (SMD) -7.59, 95% CI -14.42, -0.76, p=0.03; SMD -15.36, 95% CI -30.01, -0.71 p=0.04) but not the researcher component of the assessment tool (SMD -17.55, 95% CI -36.94, 1.84, p=0.08). Mepitel film reduced the incidence of acute RD and improved patient-reported outcomes with minimal side effects, the main one being itchiness. Future research should assess the feasibility of Mepitel film with respect to specific patient-reported outcomes such as health-related quality of life issues associated with its use.

Identifiants

pubmed: 37584828
doi: 10.1007/s00520-023-07982-2
pii: 10.1007/s00520-023-07982-2
doi:

Substances chimiques

mepitel 0
Silicones 0

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

524

Informations de copyright

© 2023. Crown.

Références

Kole AJ, Kole L, Moran M (2017) Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer Targets Ther 9:313–323
doi: 10.2147/BCTT.S109763
Alexopoulou E, Katsila T, Tolia M, Tsoukalas N, Leontsinidis M, Kyrgias G et al (2018) An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients. Anticancer Res 38(3):1615–1622
pubmed: 29491093
Radiation Dermatitis: Recognition, Prevention, and Management [Internet]. Cancer Network. Available from: https://www.cancernetwork.com/view/radiation-dermatitis-recognition-prevention-and-management
de Andrade Fuzissaki M, Paiva CE, de Oliveira MA, Canto PPL, de Paiva Maia YC (2019) The Impact of Radiodermatitis on Breast Cancer Patients’ Quality of Life during Radiotherapy: A Prospective Cohort Study. J Pain Symptom Manage 58(1):92–99.e1
doi: 10.1016/j.jpainsymman.2019.03.017
Sherman DW, Walsh SM (2022) Promoting Comfort: A Clinician Guide and Evidence-Based Skin Care Plan in the Prevention and Management of Radiation Dermatitis for Patients with Breast Cancer. Healthcare 10(8):1496
doi: 10.3390/healthcare10081496 pubmed: 36011153 pmcid: 9408725
Finkelstein S, Kanee L, Behroozian T, Wolf JR, van den Hurk C, Chow E et al (2022) Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer 30(6):4663–4674
doi: 10.1007/s00520-022-06829-6 pubmed: 35067732
Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S (2014) Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 14(1):53
doi: 10.1186/1471-2407-14-53 pubmed: 24484999 pmcid: 3909507
Shaw SZ, Nien HH, Wu CJ, Lui LT, Su JF, Lang CH (2015) 3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: A clinical trial. J Formos Med Assoc 114(5):407–414
doi: 10.1016/j.jfma.2013.04.003 pubmed: 23685085
Schmeel LC, Koch D, Stumpf S, Leitzen C, Simon B, Schüller H et al (2018) Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients. Acta Oncol 57(7):908–915
doi: 10.1080/0284186X.2018.1441542 pubmed: 29463159
Graham P, Browne L, Capp A, Fox C, Graham J, Hollis J et al (2004) Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation. Int J Radiat Oncol Biol Phys 58(1):241–246
doi: 10.1016/S0360-3016(03)01431-7 pubmed: 14697444
Graham PH, Plant N, Graham JL, Browne L, Borg M, Capp A et al (2013) A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans-Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys 86(1):45–50
doi: 10.1016/j.ijrobp.2012.12.009 pubmed: 23414763
Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H et al (2021) Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Front Oncol 29(11):738851
doi: 10.3389/fonc.2021.738851
Haruna F, Lipsett A, Marignol L (2017) Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Anticancer Res 37(10):5343–5353
pubmed: 28982842
Herst PM (2014) Protecting the radiation-damaged skin from friction: a mini review. J Med Radiat Sci 61(2):119–125
doi: 10.1002/jmrs.46 pubmed: 26229646 pmcid: 4175840
McQuestion M (2011) Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 27(2):e1–e17
doi: 10.1016/j.soncn.2011.02.009 pubmed: 21514477
Yee C, Lam E, Gallant F, Karam I, Czarnota G, Soliman H et al (2021) A Feasibility Study of Mepitel Film for the Prevention of Breast Radiation Dermatitis in a Canadian Center. Pract Radiat Oncol 11(1):e36–e45
doi: 10.1016/j.prro.2020.09.004 pubmed: 32949772
Yan J, Yuan L, Wang J, Li S, Yao M, Wang K et al (2020) Mepitel Film is superior to Biafine cream in managing acute radiation-induced skin reactions in head and neck cancer patients: a randomised intra-patient controlled clinical trial. J Med Radiat Sci 67(3):208–216
doi: 10.1002/jmrs.397 pubmed: 32475079 pmcid: 7476193
Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J et al (2022) Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial. J Clin Oncol 41(6):1250–1264
doi: 10.1200/JCO.22.01873 pubmed: 36493331
Zasadziński K, Spałek MJ, Rutkowski P (2022) Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis—a Literature Review. Pharmaceutics 14(6):1204
doi: 10.3390/pharmaceutics14061204 pubmed: 35745777 pmcid: 9229675
Møller PK, Olling K, Berg M, Habæk I, Haislund B, Iversen AM et al (2018) Breast cancer patients report reduced sensitivity and pain using a barrier film during radiotherapy – A Danish intra-patient randomized multicentre study. Tech Innov Patient Support Radiat Oncol 7:20–25
doi: 10.1016/j.tipsro.2018.05.004 pubmed: 32095578 pmcid: 7033759
Herst PM, Bennett NC, Sutherland AE, Peszynski RI, Paterson DB, Jasperse ML (2014) Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol 110(1):137–143
doi: 10.1016/j.radonc.2014.01.005 pubmed: 24486117
Wooding H, Yan J, Yuan L, Chyou TY, Gao S, Ward I et al (2018) The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study. Br J Radiol 91(1081):20170298
doi: 10.1259/bjr.20170298 pubmed: 29072852
Rades D, Narvaez CA, Splettstößer L, Dömer C, Setter C, Idel C et al (2019) A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). Radiother Oncol J Eur Soc Ther Radiol Oncol 139:79–82
doi: 10.1016/j.radonc.2019.07.023
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ 18(343):d5928
doi: 10.1136/bmj.d5928
de Aguiar BRL, Guerra ENS, Normando AGC, Martins CC, Reis PEDD, Ferreira EB (2021) Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis. Crit Rev Oncol Hematol 162:103349
doi: 10.1016/j.critrevonc.2021.103349 pubmed: 33989768
de Menêses AG, Reis PEDD, Guerra ENS, Canto GDL, Ferreira EB (2018) Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis. Rev Lat Am Enfermagem 26:e2929
doi: 10.1590/1518-8345.2035.2929 pubmed: 29742271 pmcid: 5942864
Abstracts for MASCC/ISOO Annual Meeting (2022) Support Care Cancer 30(Suppl 1):1–207. https://doi.org/10.1007/s00520-022-07099-y

Auteurs

Saba Shariati (S)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Tara Behroozian (T)

Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

Samantha Kennedy (S)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPO), Florence, Italy.

Patries M Herst (PM)

Department of Radiation Therapy, University of Otago, Wellington, New Zealand.

Liying Zhang (L)

MacroStat Inc., Toronto, Ontario, Canada.

Keyue Ding (K)

Canadian Cancer Trials Division, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.

Irene Karam (I)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Corina van den Hurk (C)

Research and Development Department, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Julie Ryan Wolf (JR)

Departments of Dermatology and Radiation Oncology, University of Rochester Medical Centre, Rochester, New York, USA.

Shing Fung Lee (SF)

Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.
Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Tuen Mun, Hong Kong.

Henry Wong (H)

Department of Oncology, Princess Margaret Hospital, Hospital Authority, Lai Chi Kok, Hong Kong.

Adrian Wai Chan (AW)

Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Tuen Mun, Hong Kong.

Mami Ogita (M)

Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.

Jason C Ye (JC)

Department of Radiation Oncology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.

Raymond J Chan (RJ)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.

Milena Gojsevic (M)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Thenugaa Rajeswaran (T)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Pierluigi Bonomo (P)

Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Edward Chow (E)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. edward.chow@sunnybrook.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH